IgG4ward’s Post

The biggest infectious risk for patients with IgG4-RD undoubtedly remains COVID. We will address COVID, vaccines, and other issues related to infection in IgG4-RD in tomorrow’s Fireside Chat. #igg4ward #igg4relateddisease

Supporting CMV Awareness Month with GeneProof Cytomegalovirus Kit! June is Cytomegalovirus (CMV) Awareness Month, a crucial time to highlight the importance of CMV testing. Often underdiagnosed, CMV is a common virus that is harmless to most people but can be dangerous to immunocompromised individuals and babies. When passed from mother to unborn child, a congenital infection can develop, leading to serious long-term health issues. By increasing awareness and providing cutting-edge diagnostic tools like the GeneProof Cytomegalovirus Kit, we can significantly impact the prevention of CMV infection. Early and accurate detection, along with viral load monitoring, is essential in improving the health and well-being of those affected by CMV. Join us in spreading awareness and promoting early detection! Why Choose GeneProof Cytomegalovirus Kit? • High Sensitivity & Specificity: Ensures accurate results, reducing false negatives and positives. • User-Friendly: Easily combinable with other GeneProof PCR kits in OneWorkflow Find out more about GeneProof CMV Kit here: https://lnkd.in/g-KqksEP #CMVAwarenessMonth #CMV #GeneProof #EarlyDetection #Diagnostics #PCR #PCRKits #PCRDiagnostics #MolecularDiagnostics

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study https://lnkd.in/eDVPRzSj https://lnkd.in/d8nUEzYu

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study https://lnkd.in/ez6f7tQ2 https://lnkd.in/eMMBvr6G

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study https://lnkd.in/eDVPRzSj https://lnkd.in/d8nUEzYu

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study https://lnkd.in/eDVPRzSj https://lnkd.in/d8nUEzYu

𝐖𝐨𝐫𝐥𝐝 𝐇𝐞𝐩𝐚𝐭𝐢𝐭𝐢𝐬 𝐃𝐚𝐲 𝟐𝟎𝟐𝟒: ‘𝐈𝐭’𝐬 𝐭𝐢𝐦𝐞 𝐟𝐨𝐫 𝐚𝐜𝐭𝐢𝐨𝐧’ The 28th of July is World Hepatitis Day, a global campaign to raise awareness and galvanise action towards eliminating viral hepatitis. Across Australia, there are nearly 300,000 people who live with chronic hepatitis B or hepatitis C. Of this total number, around 200,000 are people living with hepatitis B. While there have been tremendous developments in the treatment and prevention of both hepatitis C and B in recent years, much work remains to be done. As recent viral mapping reports (https://lnkd.in/gRZkvt9E), around 75 percent of people living with hepatitis B are not being supported by the health system to receive regular care; and over 25 percent of people living with chronic hepatitis B infection have not been supported to access testing and therefore remain undiagnosed, and potentially unaware of their infection. 𝐅𝐢𝐧𝐝 𝐨𝐮𝐭 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐜𝐞 𝐨𝐟 𝐖𝐨𝐫𝐥𝐝 𝐇𝐞𝐩𝐚𝐭𝐢𝐭𝐢𝐬 𝐃𝐚𝐲 𝐭𝐡𝐢𝐬 𝐲𝐞𝐚𝐫 𝐚𝐧𝐝 𝐰𝐚𝐲𝐬 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐭𝐡𝐞 𝐜𝐚𝐦𝐩𝐚𝐢𝐠𝐧 𝐨𝐧 𝐨𝐮𝐫 𝐛𝐥𝐨𝐠: https://lnkd.in/gzhDAW6W 𝐀𝐧𝐝 𝐬𝐢𝐠𝐧 𝐮𝐩 𝐭𝐨 𝐨𝐮𝐫 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 𝐭𝐨 𝐫𝐞𝐜𝐞𝐢𝐯𝐞 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐛𝐥𝐨𝐠 𝐩𝐨𝐬𝐭𝐬 𝐚𝐧𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐮𝐩𝐝𝐚𝐭𝐞𝐬: https://lnkd.in/gDirufba

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study https://lnkd.in/eDVPRzSj https://lnkd.in/d8nUEzYu

Co-infections are not simply the sum of their parts. In this study, researchers infected mice with Borrelia afzelii (a cause of Lyme disease in Europe) and tick-borne encephalitic virus (TBEV, another disease found in Europe). When they tried to infect mice with both at the same time, they had trouble causing a TBEV infection. They caution that this may have been an issue with their methods and not necessarily that B. afzelii infection blocks simultaneous infection with TBEV. When they infected the mice with TBEV shortly after the B. afzelii, the symptoms were worse with higher viral levels. However, if they waited 21 days, the TBEV symptoms were milder. The authors note that tick-borne disease coinfection is very common for people with Lyme disease and much more needs to be known about all possible coinfections. https://lnkd.in/eNNvYsMK

Hepatitis C crash course # 2 Testing: 1. Check a hepatitis C virus antibody. If positive, then 2. Check hepatitis C virus RNA for active infection Why is that important? Some patients get automatic clearing of hepatitis C, and patients who have been successfully treated for hepatitis C; both of those kind of cases will continue to have a positive antibody, so just having a positive antibody does not mean the patient has active infection. Please like, follow, share, repost, and comment if you like my content. I try my best to respond to every comment personally. If you want to see all of my future posts, hit the bell icon next to my profile. If you want to see all of my videos, please subscribe to my YouTube channel here. https://lnkd.in/gGg7KuBt